International Journal of Pharmaceutical and Phytopharmacological Research
ISSN (Print): 2250-1029
ISSN (Online): 2249-6084
Publish with eIJPPR Submission
2021   Volume 11   Issue 2

An Experiential Analysis of the SARS Cov-2 Infection Stages and Therapeutics from a COVID-19 Survivor
Download PDF


,
  1. Department of Life Sciences, School of Pure and Applied Sciences, South Eastern Kenya University, Kitui, Kenya.
  2. Medical Laboratory Technologist, The Nairobi Hospital, Nairobi, Kenya.
Citation
Vancouver
Kimatu JN, King'esi PK. An Experiential Analysis of the SARS Cov-2 Infection Stages and Therapeutics from a COVID-19 Survivor. Int J Pharm Phytopharmacol Res. 2021;11(2):74-9. https://doi.org/10.51847/6eRs6Z3kWb
APA
Kimatu, J. N., & King'esi, P. K. (2021). An Experiential Analysis of the SARS Cov-2 Infection Stages and Therapeutics from a COVID-19 Survivor. International Journal of Pharmaceutical And Phytopharmacological Research, 11(2), 74-79. https://doi.org/10.51847/6eRs6Z3kWb
Download citation:   EndNote   RIS
Article Link:
Abstract

In late 2019, there was an emergence of a SARS-CoV-2 strain of the coronavirus with the first reports coming from Wuhan China. This strain has since spread and mutated across the world causing a pandemic as of June 2021. The SARS-CoV-2 causes a disease called COVID-19 in the human body. The progression of the disease symptoms has not been systematically illustrated fully. This paper attempts to logically give a scientific guide on the progressive development of the symptoms experienced by most COVID-19 patients. The study is based on a personal infection of SARS CoV-2, symptom evaluation, medication, and recovery from COVID-19. It also looks comparatively at other literature and patients’ experiences. The patient data was collected during the second SARS-CoV-2 wave in Kenya with reports of the South Africa SARS CoV-2 strain being reported in the country. The study recommends a continuous pathogenies evaluation of the subsequent SAR CoV-2 variants infection pathways. This shall decipher the main attack models of the new variants and thereafter in the development and validation of COVID-19 vaccines.

Volume 15
Issue 2
2025

Call for Papers
[email protected]
Issues
Associations
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2025 International Journal of Pharmaceutical and Phytopharmacological Research
Authors retain copyright of their article if they are accepted for publication.